S P Langdon|J F Smyth - JoVE Visualize

Showing results (1-10 of 234) with videos related to

Pageof 24

Sort By:

Journal of Pharmaceutical and Biomedical Analysis|June 1, 1994

Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatographyJ Cummings, A MacLellan, S P Langdon, et al.

General Pharmacology|February 1, 1997

Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist GD A Jones, J Cummings, S P Langdon, et al.

European Journal of Cancer (Oxford, England : 1990)|February 5, 2000

Paracrine regulation of ovarian cancer by endothelinS Moraitis, W R Miller, J F Smyth, et al.

Journal of Chromatography. B, Biomedical Applications|March 4, 1994

Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detectionJ Cummings, A MacLellan, S P Langdon, et al.

Biochemical Pharmacology|August 25, 1995

Characterization of the deamidase enzyme responsible for the metabolism of the anticancer peptide: H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.

British Journal of Cancer|March 5, 2002

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")J M Sewell, K G Macleod, A Ritchie, et al.

Biochemical Pharmacology|May 26, 1995

Processing of the neuropeptide growth factor antagonist [Arg6, D-Trp7.9, NmePhe8]-substance P (6-11) by a small cell lung cancer cell line (H69)J Cummings, A J MacLellan, S P Langdon, et al.

Cancer Research|March 31, 2001

Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancerL M Gilmour, K G Macleod, A McCaig, et al.

European Journal of Cancer (Oxford, England : 1990)|June 15, 2005

The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.

Peptides|January 1, 1997

Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu miceD A Jones, A J MacLellan, J Cummings, et al.

Pageof 24

Showing results (1-10 of 234) with videos related to

Sort By:

Pageof 24

Journal of Pharmaceutical and Biomedical Analysis|June 1, 1994

Stability and in vitro metabolism of the mitogenic neuropeptide antagonists [D-Arg1,D-Phe5, D-Trp7,9, Leu11]-substance P and [Arg6, D-Trp7,9, MePhe8]-substance P (6-11) characterized by high-performance liquid chromatographyJ Cummings, A MacLellan, S P Langdon, et al.

General Pharmacology|February 1, 1997

Preclinical studies on the broad-spectrum neuropeptide growth factor antagonist GD A Jones, J Cummings, S P Langdon, et al.

European Journal of Cancer (Oxford, England : 1990)|February 5, 2000

Paracrine regulation of ovarian cancer by endothelinS Moraitis, W R Miller, J F Smyth, et al.

Journal of Chromatography. B, Biomedical Applications|March 4, 1994

Determination of two neuropeptide growth factor antagonists, [D-Arg1,D-Phe5,D-Trp7,9,Leu11]-substance P and [Arg6,D-Trp7,9,N-MePhe8]- substance P(6-11), by high-performance liquid chromatography with electrochemical detectionJ Cummings, A MacLellan, S P Langdon, et al.

Biochemical Pharmacology|August 25, 1995

Characterization of the deamidase enzyme responsible for the metabolism of the anticancer peptide: H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.

British Journal of Cancer|March 5, 2002

Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")J M Sewell, K G Macleod, A Ritchie, et al.

Biochemical Pharmacology|May 26, 1995

Processing of the neuropeptide growth factor antagonist [Arg6, D-Trp7.9, NmePhe8]-substance P (6-11) by a small cell lung cancer cell line (H69)J Cummings, A J MacLellan, S P Langdon, et al.

Cancer Research|March 31, 2001

Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancerL M Gilmour, K G Macleod, A McCaig, et al.

European Journal of Cancer (Oxford, England : 1990)|June 15, 2005

The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.

Peptides|January 1, 1997

Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu miceD A Jones, A J MacLellan, J Cummings, et al.

Pageof 24